Fresenius Medical Care AG
FMS
$22.07
-$0.03-0.14%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.31% | 3.34% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.31% | 3.34% | |||
| Cost of Revenue | -8.07% | 0.63% | |||
| Gross Profit | -16.25% | 11.29% | |||
| SG&A Expenses | -5.90% | 10.75% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 161.15% | -896.35% | |||
| Total Operating Expenses | -6.72% | 1.72% | |||
| Operating Income | -37.46% | 17.49% | |||
| Income Before Tax | -59.77% | 25.76% | |||
| Income Tax Expenses | -60.40% | 40.89% | |||
| Earnings from Continuing Operations | -59.60% | 22.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 37.87% | -42.01% | |||
| Net Income | -64.58% | 18.51% | |||
| EBIT | -37.46% | 17.49% | |||
| EBITDA | -8.04% | -8.99% | |||
| EPS Basic | -63.20% | 21.07% | |||
| Normalized Basic EPS | -37.17% | 13.36% | |||
| EPS Diluted | -63.20% | 21.17% | |||
| Normalized Diluted EPS | -37.17% | 13.36% | |||
| Average Basic Shares Outstanding | -3.73% | -2.12% | |||
| Average Diluted Shares Outstanding | -3.73% | -2.12% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||